THAI RESEARCHERS DISCOVER ANTI-CANCER FORMULA FROM MANGOSTEEN

Food and Healthcare Press Releases Wednesday August 8, 2012 16:33
Bangkok--8 Aug--Thai Mangosteen Research and Development Center

Thirty five years ago, a group of researchers at Prince of Songkhla University and Chiang Mai University successfully extracted an interesting substance from mangosteen peel. Called GM-1, the substance is found to be effective in killing bacteria that are antibiotic resistant, three times better cure of inflammation than aspirin, have better antioxidant quality than vitamin E and most importantly can effectively kill cancer cells in the lab. From such substance, the researchers produced antibacterial cream that provides better treatment of wound with Streptococci and Staphylococcus bacteria that are resistant to penicillin and methicillin. That was when mangosteen peels, which once created a lot of pollution and waste, become valuable.

In the peak of fruit season, mangosteen, like many other fruits, becomes abundant and thus the price is lower while waste increases. In 2009, a group of researcher at the Thai Mangosteen Research and Development Center, produced mangosteen juice that provides a good solution to people with imbalance immunity. The researchers controlled the GM-1 in the juice at the appropriate level in order to produce the best effect to health. Mangosteens then become even more interesting among scientists and researchers.

Now, new discovery of the purple skin fruits, which are known as the Queen of Thai fruits, has stunned the global medical industry. Asian Phytoceuticals Public Company Limited’s Thai Mangosteen Research and Development Center, in cooperation with Chiang Mai University have conducted a research further on GM-1 admixed formula at the Biomedical Technology Research Center, Chiang Mai University, and found that at controlled level, such natural extract from mangosteen effectively produce balancing immunity (BIM). At different levels, the natural extract produces different results. It is therefore very effective in treating patients with different problems related to imbalance immunity. In the experiment, it is found that volunteers who consumed 2 gm of BIM substance for 15 days, Th1 cells doubled while TH17 cells were increased by 5 times.

It is known for more than 20 years among immunologists that Th1, a type of white blood cells enable body immunity to effectively eliminate foreign cells, such a fungi, bacteria, virus and cancer cells. Th17 cells were discovered in 2007 and found to be highly effective in preventing cancer cells to grow and inhibiting cancer symptoms. The discovery that BIM can increase the number of the two white blood cells, especially Th17, is a real breakthrough.

Prof. Dr. Pichaet Wiriyachitra, head researcher, Thai Mangosteen Research and Development Center, commented on the discovery of BIM and its effectiveness in promotion Th17:

“We are so proud of Thai researchers for this valuable discovery. Starting from GM-1 discovery, our brilliant researchers mixed it with natural extracts from guava, black sesame, soybeans and Asiatic Pennywort. Thanks to their knowledge, more than 30-year experience and creativity, they successfully formulate BIM which is effective in achieving immunity balance without any side effect. We believe this will help enhance quality of life of cancer patients.”

In its commitment to research and development for quality of life of consumers, Asian Phytoceuticals PCL fully supports the test of BIM on cancer patients at Chiang Mai University’s Faculty of Medicine. The researchers tested the extracts on final stage lung cancer patients who do not anymore respond to chemotherapy, conducted under supervision of Prof. Sumitra Thongprasert, MD, as well as patients suffering from other kinds of cancers who do not respond to normal therapy in the US and Italy. The result is very positive. It effectively enhanced quality of life of the patients and significant prolonged the life expectancy of final stage cancer patients who do not respond to normal chemotherapy.

While there is not yet completely safe and efficient way to expand Th17 in huge volume enough to treat cancer patients, the fruit extracts discovered by the Thai researcher team emerged as an interesting solution. More importantly, the natural extracts are proven safe and effective and are produced at lower cost of production compared to other medicine imported from other countries.

Given the significant success on BIM, quality of life of cancer patients will be significantly improved. In addition, it is believed to create greater economic value and social contribution to Thailand while natural resources are utilized.

For more information about BIM and the mangosteen extract, please contact the Thai Mangosteen Research and Development Center at Tel. 0 2 646 4 800

Latest Press Release

Grunenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US

Grunenthal announced today that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint to the United States. Averitas Pharma will be commercialising the pain patch Qutenza(R) (8 % capsaicin) for...

Ascensia Diabetes Care Highlights the Support That Families Provide for People With Diabetes To Mark World Diabetes Day 2018

Today, Ascensia Diabetes Care, a global leading diabetes care company, launched their campaign for World Diabetes Day 2018 to celebrate the important role of families for people with diabetes. They are publishing 38 online artworks that tell the stories...

Qatar Foundation Ushers in New Era of Healthcare With Official Inauguration of Sidra Medicine

Her Highness Sheikha Moza bint Nasser, Chairperson of Qatar Foundation (QF), today officially inaugurated Sidra Medicine - a brand new, world-leading women's and children's hospital in Qatar. The grand opening reflects the country's broader focus and...

Singapore National Eye Centre, Singapore Eye Research Institute And Johnson Johnson Vision Set Sights On Halting Global Myopia Epidemic

New US$26.35 Million Collaboration Seeks Prevention and Treatment Solutions to Address Rising Burden of Condition The Singapore National Eye Centre (SNEC), the Singapore Eye Research Institute (SERI) and Johnson & Johnson Vision today announced a...

TIENS Group Launches Global Expansion Into New Retail

Leading healthcare company, TIENS Group, has announced their global expansion into the new retail market with the opening of a new flagship TIENS Experience Store in China. Located in the TIENS International Health Industrial Park, the new store features...

Related Topics